We recently compiled a list of the 10 Best Multibagger Penny Stocks of 2025. In this article, we are going to take a look at where Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stands against the other multibagger penny stocks. What Are Multibagger Stocks And How To Identify Them The term “multibagger” was coined by Peter Lynch in his […]
Regeneron (REGN) and Lexicon (LXRX) are in the spotlight following drug approval and regulatory update, respectively.
The FDA plans to hold an Advisory Committee meeting to give a recommendation for Lexicon's (LXRX) Zynquista (sotagliflozin) on Oct 31, 2024. Stock up.